Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Pathophysiology characterization of Alzheimer’s disease in South China’s aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)

Fig. 3

Comparisons of plasma biomarkers and neuroimaging between different clinical groups. Comparisons of (A) plasma Aβ42/Aβ40, (B) plasma p-Tau181, (C) plasma GFAP, (D) plasma NfL, (E) Aβ PET, (F) tau PET, (G) hippocampal volume and (H) temporal-MetaROI cortical thickness between NC, SCD, MCI, and dementia groups. Plasma p-Tau181, plasma GFAP, and plasma NfL were log10 transferred. The mean intra-assay and inter-assay coefficient of variation (CV)s were respectively 12% and 17% for plasma Aβ42, 9% and 17% for plasma Aβ40, 7% and 9% for plasma NfL, 5% and 14% for plasma GFAP, and 10% and 13% for plasma p-Tau181

Back to article page